Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor

Imatinib mesylate is currently used as the first-line treatment for metastatic gastrointestinal stromal tumors (GISTs). Imatinib-induced hepatotoxicity in patients with GIST is very rare. Its features vary from subclinical elevation of serum aminotransferase to clinically apparent acute hepatitis, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Min Kyu, Lee, Heon Ju, Choi, Joon Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yeungnam University College of Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784631/
https://www.ncbi.nlm.nih.gov/pubmed/31620629
http://dx.doi.org/10.12701/yujm.2019.00115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784631/
https://www.ncbi.nlm.nih.gov/pubmed/31620629
http://dx.doi.org/10.12701/yujm.2019.00115

Ejemplares similares